HB 1286 Indiana House · 2023 Regular Session

Toxicology screening for xylazine.

Summary
Provides that, if the coroner reasonably suspects the cause of the person's death to be accidental or intentional overdose of an opioid or if the person was administered an overdose intervention drug prior to death and was unresponsive to the overdose intervention drug, the coroner shall test certain bodily fluids to determine whether the bodily fluid contained any amount, including a trace amount, of xylazine at the time of the person's death.
Bill status signed all 5 stages cleared
Introduction
Jan 2023
Committee Review
Mar 2023
House Passage
Apr 2023
Senate Passage
Apr 2023
Signed into Law
Apr 2023
Introduced Jan 11, 2023 Signed Apr 20, 2023
Floor votes · Senate Mar 27, 2023

How they voted

470
Passed · 1 other
Total votes 48
Mar 27, 2023
D Democratic10
10 Yea
100% Yea
R Republican38
37 Yea 1
97% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
21
Key actions
8
Committee
2
Apr 20, 2023
Signed into law
Signed by the Governor
executive
Apr 17, 2023
Upper · Passed
Signed by the President of the Senate
upper
Apr 4, 2023
Upper · Passed
Signed by the President Pro Tempore
upper
Apr 3, 2023
Lower · Passed
Signed by the Speaker
lower
Mar 27, 2023
Upper · Passed
Third reading: passed; Roll Call 253: yeas 49, nays 0
upper
Mar 20, 2023
Upper · Passed
Committee report: do pass, adopted
upper
Feb 20, 2023
Lower · Passed
Third reading: passed; Roll Call 154: yeas 96, nays 0
lower
Feb 14, 2023
Lower · Passed
Committee report: do pass, adopted
lower
3 primary · 4 co-sponsors

Sponsors